Soleno Therapeutics Inc
NASDAQ:SLNO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
US |
|
M
|
Meta Platforms Inc
F:FB2A
|
US |
|
Bharat Bijlee Ltd
NSE:BBL
|
IN |
|
RH
NYSE:RH
|
US |
|
E
|
Electricite de France SA
F:E2F
|
FR |
|
Fuyao Glass Industry Group Co Ltd
OTC:FIGIF
|
CN |
|
B
|
BuzzFeed Inc
NASDAQ:BZFD
|
US |
|
GE Vernova Inc
MIL:1GEV
|
US |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
|
M
|
Metcash Ltd
OTC:MCSHF
|
AU |
|
Thor Industries Inc
NYSE:THO
|
US |
|
Axalta Coating Systems Ltd
NYSE:AXTA
|
US |
|
C
|
Cardinal Health Inc
F:CLH
|
US |
|
B
|
Blue Sky Uranium Corp
OTC:BKUCF
|
CA |
Wall St Price Targets
SLNO Price Targets Summary
Soleno Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for SLNO is 57.53 USD with a low forecast of 53.53 USD and a high forecast of 84 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SLNO's stock price target?
Price Target
57.53
USD
According to Wall Street analysts, the average 1-year price target for SLNO is 57.53 USD with a low forecast of 53.53 USD and a high forecast of 84 USD.
What is the Revenue forecast for Soleno Therapeutics Inc?
Projected CAGR
75%
Over the last 12 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 3 years is 75%.
What is the Operating Income forecast for Soleno Therapeutics Inc?
Projected CAGR
307%
The compound annual growth rate for Operating Income over the next 3 years is 307%.
What is the Net Income forecast for Soleno Therapeutics Inc?
Projected CAGR
188%
The compound annual growth rate for Net Income over the next 3 years is 188%.
